Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension-Reference-Cited by-同舟云学术

Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension

Published:2021-06-16 Issue:8 Volume:39 Page:1522-1545
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Kasiakogias Alexandros,Rosei Enrico Agabiti,Camafort Miguel,Ehret Georg,Faconti Luca,Ferreira João Pedro,Brguljan Jana,Januszewicz Andrzej,Kahan Thomas,Manolis Athanasios,Tsioufis Konstantinos,Weber Thomas,von Lueder Thomas G.,Smiseth Otto A.,Wachtell Kristian,Kjeldsen Sverre E.,Zannad Faiez,Mancia Giuseppe,Kreutz Reinhold

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference213 articles.

1. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension;Williams;J Hypertens,2018

2. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes;Shah;J Am Coll Cardiol,2017

3. Epidemiology and clinical course of heart failure with preserved ejection fraction;Lam;Eur J Heart Fail,2011

4. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response;Kao;Eur J Heart Fail,2015

5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Ponikowski;Eur Heart J,2016

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum N-Terminal Pro-B-Type Natriuretic Peptide Level is Negatively Associated with Vascular Reactivity Index by Digital Thermal Monitoring in Patients with Hypertension;Reviews in Cardiovascular Medicine;2024-06-14

2. Heart failure management with β-blockers: can we do better?;Current Medical Research and Opinion;2024-04

3. Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?;Blood Pressure;2024-03-31

4. Prevention and treatment of hypertensive left ventricular hypertrophy;Current Opinion in Cardiology;2024-03-05

5. Heart Failure with Preserved Ejection Fraction: How to Deal with This Chameleon;Journal of Clinical Medicine;2024-02-28